Cargando…

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

We characterized virus-neutralization and spike-binding antibody profiles in myeloma patients following monovalent or bivalent-SARS-CoV-2 booster vaccination. Vaccination improves the breadth of binding antibodies but not neutralization activity against current variants. Hybrid immunity and immune i...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno, Alberto, Manning, Kelly, Azeem, Maryam I., Nooka, Ajay K., Ellis, Madison, Manalo, Renee Julia, Switchenko, Jeffrey M., Wali, Bushra, Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Dhodapkar, Kavita M., Dhodapkar, Madhav V., Suthar, Mehul S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543400/
https://www.ncbi.nlm.nih.gov/pubmed/37790523
http://dx.doi.org/10.21203/rs.3.rs-3293339/v1
_version_ 1785114292404617216
author Moreno, Alberto
Manning, Kelly
Azeem, Maryam I.
Nooka, Ajay K.
Ellis, Madison
Manalo, Renee Julia
Switchenko, Jeffrey M.
Wali, Bushra
Kaufman, Jonathan L.
Hofmeister, Craig C.
Joseph, Nisha S.
Lonial, Sagar
Dhodapkar, Kavita M.
Dhodapkar, Madhav V.
Suthar, Mehul S.
author_facet Moreno, Alberto
Manning, Kelly
Azeem, Maryam I.
Nooka, Ajay K.
Ellis, Madison
Manalo, Renee Julia
Switchenko, Jeffrey M.
Wali, Bushra
Kaufman, Jonathan L.
Hofmeister, Craig C.
Joseph, Nisha S.
Lonial, Sagar
Dhodapkar, Kavita M.
Dhodapkar, Madhav V.
Suthar, Mehul S.
author_sort Moreno, Alberto
collection PubMed
description We characterized virus-neutralization and spike-binding antibody profiles in myeloma patients following monovalent or bivalent-SARS-CoV-2 booster vaccination. Vaccination improves the breadth of binding antibodies but not neutralization activity against current variants. Hybrid immunity and immune imprinting impact vaccine-elicited immunity.
format Online
Article
Text
id pubmed-10543400
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-105434002023-10-03 Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity Moreno, Alberto Manning, Kelly Azeem, Maryam I. Nooka, Ajay K. Ellis, Madison Manalo, Renee Julia Switchenko, Jeffrey M. Wali, Bushra Kaufman, Jonathan L. Hofmeister, Craig C. Joseph, Nisha S. Lonial, Sagar Dhodapkar, Kavita M. Dhodapkar, Madhav V. Suthar, Mehul S. Res Sq Article We characterized virus-neutralization and spike-binding antibody profiles in myeloma patients following monovalent or bivalent-SARS-CoV-2 booster vaccination. Vaccination improves the breadth of binding antibodies but not neutralization activity against current variants. Hybrid immunity and immune imprinting impact vaccine-elicited immunity. American Journal Experts 2023-09-21 /pmc/articles/PMC10543400/ /pubmed/37790523 http://dx.doi.org/10.21203/rs.3.rs-3293339/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Moreno, Alberto
Manning, Kelly
Azeem, Maryam I.
Nooka, Ajay K.
Ellis, Madison
Manalo, Renee Julia
Switchenko, Jeffrey M.
Wali, Bushra
Kaufman, Jonathan L.
Hofmeister, Craig C.
Joseph, Nisha S.
Lonial, Sagar
Dhodapkar, Kavita M.
Dhodapkar, Madhav V.
Suthar, Mehul S.
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity
title Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity
title_full Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity
title_fullStr Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity
title_full_unstemmed Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity
title_short Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity
title_sort divergence of variant binding/neutralizing antibodies following sars-cov-2 booster vaccines in myeloma: impact of hybrid immunity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543400/
https://www.ncbi.nlm.nih.gov/pubmed/37790523
http://dx.doi.org/10.21203/rs.3.rs-3293339/v1
work_keys_str_mv AT morenoalberto divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT manningkelly divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT azeemmaryami divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT nookaajayk divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT ellismadison divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT manaloreneejulia divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT switchenkojeffreym divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT walibushra divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT kaufmanjonathanl divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT hofmeistercraigc divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT josephnishas divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT lonialsagar divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT dhodapkarkavitam divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT dhodapkarmadhavv divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity
AT sutharmehuls divergenceofvariantbindingneutralizingantibodiesfollowingsarscov2boostervaccinesinmyelomaimpactofhybridimmunity